About US
Contact us
-
Patent expiries 'pose challenge to enzyme inhibitor market growth'A number of existing enzyme inhibitors will reach the end of their patent terms in the near future and this could have a significant effect on market growth, analysts have said.TechNavio estimates t2012/10/18
-
Type-2 diabetes drug market set to double by 2021The market for drugs designed to treat type-2 diabetes will almost double over the next ten years, experts have predicted.Last year, the market in the US, France, Germany, Italy, Spain, the UK and J2012/10/18
-
Global autologous cell therapy market worth $2.2bn by 2017Autologous cell therapies (ACTs) are likely to revolutionise the markets for biopharmaceuticals and personalised medicines in the coming years, a report has claimed.An ACT is one where cells are harve2012/10/17
-
Type-2 diabetes drug market set to double by 2021The market for drugs designed to treat type-2 diabetes will almost double over the next ten years, experts have predicted.Last year, the market in the US, France, Germany, Italy, Spain, the UK and Jap2012/10/17
-
Dedicated budgets for medical publication teams 'linked to higher output'In-house medical publication teams that have dedicated budgets in place tend to produce a greater number of manuscripts and abstracts each year, a study has found. Cutting Edge Information surveyed2012/10/16
-
GSK adopts new transparency policyGlaxoSmithKline's (GSK) chief executive has announced a new transparency policy that will see the pharmaceutical company share detailed clinical trial data with the wider scientific community. A newl2012/10/16
-
Novartis, Sanofi unveil data backing their rival MS pillsNovartis is touting a new data analysis suggesting that early treatment with its multiple sclerosis drugGilenyacan ward off relapses--and even prevent the loss of brain volume that often plaguesMSpati2012/10/15
-
Pfizer fleshes out Zoetis executive teamPfizer ($PFE) added to its lineup atZoetis, the animal health unit preparing for a spinoff. The drugmaker tapped 9 executive vice presidents to back up previously appointed CEO Juan Ramon Alaix. Amon2012/10/15
-
Report spies opportunity for ankylosing spondylitis drug developmentBiopharmaceutical companies have a major opportunity in the form of drug development for ankylosing spondylitis (AS), a report suggests.The chronic inflammatory disease has few treatment options, wi2012/10/12
-
Dedicated budgets for medical publication teams 'linked to higher output'In-house medical publication teams that have dedicated budgets in place tend to produce a greater number of manuscripts and abstracts each year, a study has found. Cutting Edge Information surveyed2012/10/12